News | Radiation Oncology | May 18, 2021

Comprehensive approach to complex cases enables broad access to exceptional medical expertise from world-renowned specialists at Cleveland Clinic

The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis.

May 18, 2021 — The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis. The Clinic’s virtual second opinion offering provides patients, including those with complex medical conditions, the ability to obtain support from Cleveland Clinic’s world-renowned multidisciplinary panels, whose diversity of expertise ensures the most comprehensive and coordinated second opinion and treatment plan is offered.

“We chose to enter into the multi-disciplinary opinion space by offering services for brain tumor and prostate cancers because there are multiple treatment options for these patients,” said Peter Rasmussen, M.D., Chief Clinical Officer with The Clinic. “Given that these cancers can be treated with surgery, chemotherapeutics, and/or several different types of radiation, one physician isn't able to deliver a holistic opinion. Only multiple physicians from multiple specialties can provide the best recommendation to yield the highest quality of care and thereby the best value care. Our goal is to give patients access to Cleveland Clinic’s vast medical expertise from a variety of different perspectives for the best patient outcomes.”

According to a study published by the National Institutes of Health, more than 40% of cancer patients seeking a second opinion had a change in diagnosis as a result of multidisciplinary panel review, while 23% of patients were determined to present with additional, previously-undiagnosed cancers.

Added Frank McGillin, CEO of The Clinic, “Pairing patients who have complex medical conditions with coordinated support for multidisciplinary review reduces the risk of suboptimal treatment plans. It also protects them from higher-than-necessary healthcare expenses while providing peace of mind that they’re on the right path. For employers and health plans, the right diagnosis and treatment equates to better member outcomes and reduced costs of care.”

For more information: www.theclinic.io


Related Content

News | Radiology Business

The American Society of Radiologic Technologists (ASRT) will host a free Virtual Career Fair on March 17, from 4-7 p.m ...

Time February 20, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
Feature | Artificial Intelligence

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Radiology Business

Feb. 3, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time February 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
Subscribe Now